Whittier Trust’s Acorda Therapeutics ACOR Stock Holding History

Whittier Trust’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2	Closed	-$4K	–	1518
2018 Q4	$4K	Hold	2	–	–	﹤0.01%	1202
2018 Q3	$5K	Hold	2	–	–	﹤0.01%	1129
2018 Q2	$7K	Hold	2	–	–	﹤0.01%	1069
2018 Q1	$6K	Hold	2	–	–	﹤0.01%	1128
2017 Q4	$5K	Sell	2 -305	-99%	-$867K	﹤0.01%	1132
2017 Q3	$872K	Buy	307 +4	+1%	+$10.5K	0.03%	296
2017 Q2	$716K	Buy	303 +8	+3%	+$15.8K	0.03%	299
2017 Q1	$744K	Buy	295 +17	+6%	+$48.9K	0.03%	296
2016 Q4	$628K	Hold	278	–	–	0.03%	311
2016 Q3	$697K	Sell	278 -1	-0.4%	-$2.98K	0.03%	305
2016 Q2	$855K	Buy	279 +3	+1%	+$9.76K	0.04%	271
2016 Q1	$876K	Hold	276	–	–	0.04%	267
2015 Q4	$1.42M	Buy	276 +3	+1%	+$13.1K	0.06%	219
2015 Q3	$868K	Hold	273	–	–	0.04%	267
2015 Q2	$1.09M	Hold	273	–	–	0.05%	259
2015 Q1	$1.09M	Hold	273	–	–	0.05%	253
2014 Q4	$1.34M	Hold	273	–	–	0.06%	216
2014 Q3	$1.11M	Hold	273	–	–	0.05%	229
2014 Q2	$1.1M	Hold	273	–	–	0.05%	231
2014 Q1	$1.24M	Hold	273	–	–	0.06%	209
2013 Q4	$957K	Hold	273	–	–	0.05%	245
2013 Q3	$1.12M	Sell	273 -31	-10%	-$134K	0.06%	220
2013 Q2	$1.2M	Buy	+304	New	+$1.25M	0.07%	193

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Whittier Trust's ACOR Position: Q1 2019 in Review

Whittier Trust sold out of Acorda Therapeutics (ACOR) in Q1 2019, closing a stake of 2 shares — an estimated $4K sold.

Whittier Trust first reported a position in ACOR in Q2 2013 and held it in 23 quarters. The position peaked at $1.42M in Q4 2015. 184 funds tracked by Wall St. Rank hold ACOR as of Q1 2019.

Whittier Trust reported no remaining Acorda Therapeutics position as of Q1 2019 after selling out during the quarter.
Whittier Trust sold 2 Acorda Therapeutics shares in Q1 2019, an estimated $4K.
Whittier Trust first reported a position in Acorda Therapeutics in Q2 2013 and held it in 23 quarters.
Whittier Trust's Acorda Therapeutics position peaked at $1.42M in Q4 2015.
184 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2019.

Based on Whittier Trust's 13F filing for Q1 2019, filed 29 Apr 2019.